{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:15:39Z","timestamp":1787318139184,"version":"build-2736575974"},"publisher-location":"Basel","reference-count":93,"publisher":"Springer Basel","isbn-type":[{"value":"9783034808361","type":"print"},{"value":"9783034808378","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-3-0348-0837-8_12","type":"book-chapter","created":{"date-parts":[[2014,5,12]],"date-time":"2014-05-12T08:47:09Z","timestamp":1399884429000},"page":"315-333","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["The Role of Inflammation in Lymphoma"],"prefix":"10.1007","author":[{"given":"Antonino","family":"Carbone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Tripodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Carlo-Stella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annunziata","family":"Gloghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,13]]},"reference":[{"issue":"4","key":"12_CR1","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/ijc.23119","volume":"122","author":"D Aldinucci","year":"2008","unstructured":"Aldinucci D, Lorenzon D, Cattaruzza L, Pinto A, Gloghini A, Carbone A, Colombatti (2008) Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5\/RANTES in tumour cell growth and microenvironmental interactions. Int J Cancer 122(4):769\u2013776","journal-title":"Int J Cancer"},{"issue":"3","key":"12_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/path.2711","volume":"221","author":"D Aldinucci","year":"2010","unstructured":"Aldinucci D, Gloghini A, Pinto A, De Filippi R, Carbone A (2010) The classical Hodgkin\u2019s lymphoma microenvironment and its role in promoting tumour growth and immune escape. J Pathol 221(3):248\u2013263","journal-title":"J Pathol"},{"issue":"2","key":"12_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1365-2141.2010.08497.x","volume":"152","author":"D Aldinucci","year":"2011","unstructured":"Aldinucci D, Celegato M, Borghese C, Colombatti A, Carbone A (2011) IRF4 silencing inhibits Hodgkin lymphoma cell proliferation, survival and CCL5 secretion. Br J Haematol 152(2):182\u2013190","journal-title":"Br J Haematol"},{"issue":"9","key":"12_CR4","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/ni1100","volume":"5","author":"CD Allen","year":"2004","unstructured":"Allen CD, Ansel KM, Low C, Lesley R, Tamamura H, Fujii N et al (2004) Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol 5(9):943\u2013952","journal-title":"Nat Immunol"},{"issue":"6793","key":"12_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/35018581","volume":"406","author":"KM Ansel","year":"2000","unstructured":"Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster R, Sedgwick JD et al (2000) A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406(6793):309\u2013314","journal-title":"Nature"},{"issue":"1","key":"12_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3960\/jslrt.46.5","volume":"46","author":"K Aozasa","year":"2006","unstructured":"Aozasa K (2006) Pyothorax-associated lymphoma. J Clin Exp Hematop 46(1):5\u201310","journal-title":"J Clin Exp Hematop"},{"issue":"16","key":"12_CR7","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1182\/blood-2009-06-225326","volume":"114","author":"JA Burger","year":"2009","unstructured":"Burger JA, Ghia P, Rosenwald A, Caligaris-Cappio F (2009) The microenvironment in mature B cell malignancies: a target for new treatment strategies. Blood 114(16):3367\u20133375","journal-title":"Blood"},{"issue":"3","key":"12_CR8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1200\/JCO.2007.12.8298","volume":"26","author":"D Canioni","year":"2008","unstructured":"Canioni D, Salles G, Mounier N, Brousse N, Keuppens M, Morchhauser F, Lamy T, Sonet A, Rousselet MC, Foussard C, Xerri L (2008) High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial. J Clin Oncol 26(3):440\u2013446. doi:10.1200\/JCO.2007.12.8298","journal-title":"J Clin Oncol"},{"issue":"8455","key":"12_CR9","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0140-6736(85)90619-1","volume":"2","author":"A Carbone","year":"1985","unstructured":"Carbone A, Manconi R, Poletti A, Volpe R (1985) Practical importance of immunostaining paraffin-embedded biopsy samples of small lymphocytic and follicle centre cell lymphomas for S100 protein. Lancet 2(8455):617","journal-title":"Lancet"},{"issue":"4","key":"12_CR10","first-page":"912","volume":"147","author":"A Carbone","year":"1995","unstructured":"Carbone A, Gloghini A, Gruss HJ, Pinto A (1995) CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin\u2019s disease. Am J Pathol 147(4):912\u2013922","journal-title":"Am J Pathol"},{"issue":"2","key":"12_CR11","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1046\/j.1365-2141.2002.03456.x","volume":"117","author":"A Carbone","year":"2002","unstructured":"Carbone A, Gloghini A, Aldinucci D, Gattei V, Dalla-Favera R, Gaidano G (2002) Expression pattern of MUM1\/IRF4 in the spectrum of pathology of Hodgkin\u2019s disease. Br J Haematol 117(2):366\u2013372","journal-title":"Br J Haematol"},{"issue":"4","key":"12_CR12","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1365-2141.2009.07651.x","volume":"145","author":"A Carbone","year":"2009","unstructured":"Carbone A, Gloghini A, Cabras A, Elia G (2009) The Germinal centre-derived lymphomas seen through their cellular microenvironment. Br J Haematol 145(4):468\u2013480","journal-title":"Br J Haematol"},{"issue":"9","key":"12_CR13","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1200\/JCO.2008.18.0513","volume":"27","author":"J Carreras","year":"2009","unstructured":"Carreras J, Lopez-Guillermo A, Roncador G, Villamor N, Colomo L, Martinez A, Hamoudi R, Howat WJ, Montserrat E, Campo E (2009) High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma. J Clin Oncol 27(9):1470\u20131476. doi:10.1200\/JCO.2008.18.0513","journal-title":"J Clin Oncol"},{"issue":"22","key":"12_CR14","doi-asserted-by":"publisher","first-page":"9166","DOI":"10.1158\/0008-5472.CAN-10-2460","volume":"70","author":"KJ Cheung","year":"2010","unstructured":"Cheung KJ, Johnson NA, Affleck JG, Severson T, Steidl C, Ben-Neriah S et al (2010) Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis. Cancer Res 70(22):9166\u20139174","journal-title":"Cancer Res"},{"issue":"2","key":"12_CR15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/CJI.0b013e31815b69c8","volume":"31","author":"P Correale","year":"2008","unstructured":"Correale P, Del Vecchio MT, La Placa M, Montagnani F, Di Genova G, Savellini GG, Terrosi C, Mannucci S, Giorgi G, Francini G, Cusi MG (2008) Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs. J Immunother 31(2):132\u2013147. doi:10.1097\/CJI.0b013e31815b69c8","journal-title":"J Immunother"},{"issue":"1","key":"12_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1365-2559.2010.03706.x","volume":"58","author":"SE Coupland","year":"2011","unstructured":"Coupland SE (2011) The challenge of the microenvironment in B-cell lymphomas. Histopathology 58(1):69\u201380. doi:10.1111\/j.1365-2559.2010.03706.x","journal-title":"Histopathology"},{"issue":"5\u20136","key":"12_CR17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/10428199809057606","volume":"31","author":"F Dammacco","year":"1998","unstructured":"Dammacco F, Gatti P, Sansonno D (1998) Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin\u2019s lymphoma: an emerging picture. Leuk Lymphoma 31(5\u20136):463\u2013476","journal-title":"Leuk Lymphoma"},{"issue":"21","key":"12_CR18","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1056\/NEJMoa041869","volume":"351","author":"SS Dave","year":"2004","unstructured":"Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC et al (2004) Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 351(21):2159\u20132169","journal-title":"N Engl J Med"},{"key":"12_CR19","doi-asserted-by":"publisher","unstructured":"de Jong D, Fest T (2011) The microenvironment in follicular lymphoma. Best Pract Res Clin Haematol 24(2):135\u2013146. doi:10.1016\/j.beha.2011.02.007. (Epub 2011 May 17)","DOI":"10.1016\/j.beha.2011.02.007"},{"issue":"5","key":"12_CR20","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1182\/blood.V86.5.1887.bloodjournal8651887","volume":"86","author":"S De Vita","year":"1995","unstructured":"De Vita S, Sansonno D, Dolcetti R, Ferraccioli G, Carbone A, Cornacchiulo V et al (1995) Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 86(5):1887\u20131892","journal-title":"Blood"},{"issue":"4","key":"12_CR21","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/00000478-200604000-00009","volume":"30","author":"J Dupuis","year":"2006","unstructured":"Dupuis J, Boye K, Martin N, Copie-Bergman C, Plonquet A, Fabiani B et al (2006) Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol 30(4):490\u2013494","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"12_CR22","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1182\/blood-2005-04-1565","volume":"106","author":"P Farinha","year":"2005","unstructured":"Farinha P, Masoudi H, Skinnider BF, Shumansky K, Spinelli JJ, Gill K, Klasa R, Voss N, Connors JM, Gascoyne RD (2005) Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood 106(6):2169\u20132174. doi:10.1182\/blood-2005-04-1565","journal-title":"Blood"},{"issue":"12","key":"12_CR23","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.3324\/haematol.2009.021766","volume":"95","author":"P Farinha","year":"2010","unstructured":"Farinha P, Kyle AH, Minchinton AI, Connors JM, Karsan A, Gascoyne RD (2010) Vascularization predicts overall survival and risk of transformation in follicular lymphoma. Haematologica 95(12):2157\u20132160. doi:10.3324\/haematol.2009.021766","journal-title":"Haematologica"},{"issue":"4","key":"12_CR24","first-page":"1044","volume":"143","author":"M Fukayama","year":"1993","unstructured":"Fukayama M, Ibuka T, Hayashi Y, Ooba T, Koike M, Mizutani S (1993) Epstein-Barr virus in pyothorax-associated pleural lymphoma. Am J Pathol 143(4):1044\u20131049","journal-title":"Am J Pathol"},{"key":"12_CR25","doi-asserted-by":"publisher","unstructured":"Gascoyne RD, Steidl C (2011) VII. The role of the microenvironment in lymphoid cancers. Ann Oncol 22 (Suppl 4):iv47\u2013iv50. doi:10.1093\/annonc\/mdr173","DOI":"10.1093\/annonc\/mdr173"},{"issue":"3","key":"12_CR26","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/hep.510300323","volume":"30","author":"G Germanidis","year":"1999","unstructured":"Germanidis G, Haioun C, Dhumeaux D, Reyes F, Pawlotsky JM (1999) Hepatitis C virus infection, mixed cryoglobulinemia, and B-cell non-Hodgkin\u2019s lymphoma. Hepatology 30(3):822\u2013823","journal-title":"Hepatology"},{"issue":"2","key":"12_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ccr.2013.01.008","volume":"23","author":"G Germano","year":"2013","unstructured":"Germano G, Frapolli R, Belgiovine C, Anselmo A, Pesce S, Liguori M, Erba E, Uboldi S, Zucchetti M, Pasqualini F, Nebuloni M, van Rooijen N, Mortarini R, Beltrame L, Marchini S, Fuso Nerini I, Sanfilippo R, Casali PG, Pilotti S, Galmarini CM, Anichini A, Mantovani A, D\u2019Incalci M, Allavena P (2013) Role of macrophage targeting in the antitumor activity of trabectedin. Cancer Cell 23(2):249\u2013262. doi:10.1016\/j.ccr.2013.01.008","journal-title":"Cancer Cell"},{"issue":"1","key":"12_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0046-8177(93)90065-O","volume":"24","author":"A Gloghini","year":"1993","unstructured":"Gloghini A, Carbone A (1993) The nonlymphoid microenvironment of reactive follicles and lymphomas of follicular origin as defined by immunohistology on paraffin-embedded tissues. Hum Pathol 24(1):67\u201376","journal-title":"Hum Pathol"},{"issue":"8","key":"12_CR29","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/0046-8177(90)90047-9","volume":"21","author":"A Gloghini","year":"1990","unstructured":"Gloghini A, Volpe R, Carbone A (1990) Vimentin immunostaining in fibroblastic reticulum cells within human reactive and neoplastic lymphoid follicles. Hum Pathol 21(8):792\u2013798","journal-title":"Hum Pathol"},{"issue":"11","key":"12_CR30","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00109-012-0906-z","volume":"90","author":"UE Hopken","year":"2012","unstructured":"Hopken UE, Rehm A (2012) Homeostatic chemokines guide lymphoma cells to tumor growth-promoting niches within secondary lymphoid organs. J Mol Med 90(11):1237\u20131245","journal-title":"J Mol Med"},{"issue":"2","key":"12_CR31","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1046\/j.1365-2141.2002.03832.x","volume":"119","author":"H Husson","year":"2002","unstructured":"Husson H, Freedman AS, Cardoso AA, Schultze J, Munoz O, Strola G et al (2002) CXCL13 (BCA-1) is produced by follicular lymphoma cells: role in the accumulation of malignant B cells. Br J Haematol 119(2):492\u2013495","journal-title":"Br J Haematol"},{"key":"12_CR32","unstructured":"IARC (2012) Monographs on the evaluation of carcinogenic risks to humans. In: ARC monographs on the evaluation of carcinogenic risks to humans, vol 100B. Biological Agents, Lyon, France"},{"issue":"5","key":"12_CR33","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","volume":"115","author":"J Iqbal","year":"2010","unstructured":"Iqbal J, Weisenburger DD, Greiner TC, Vose JM, McKeithan T, Kucuk C et al (2010) Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 115(5):1026\u20131036","journal-title":"Blood"},{"key":"12_CR34","first-page":"233","volume":"30","author":"ES Jaffe","year":"1997","unstructured":"Jaffe ES, Wilson WH (1997) Lymphomatoid granulomatosis: pathogenesis, pathology and clinical implications. Cancer Surv 30:233\u2013248","journal-title":"Cancer Surv"},{"issue":"1","key":"12_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri2217","volume":"8","author":"U Klein","year":"2008","unstructured":"Klein U, Dalla-Favera R (2008) Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 8(1):22\u201333","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"12_CR36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/1078-0432.154.11.1","volume":"11","author":"A Koster","year":"2005","unstructured":"Koster A, van Krieken JH, Mackenzie MA, Schraders M, Borm GF, van der Laak JA, Leenders W, Hebeda K, Raemaekers JM (2005) Increased vascularization predicts favorable outcome in follicular lymphoma. Clin Cancer Res 11(1):154\u2013161","journal-title":"Clin Cancer Res"},{"issue":"8","key":"12_CR37","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1097\/00000478-200008000-00004","volume":"24","author":"MD Kraus","year":"2000","unstructured":"Kraus MD, Haley J (2000) Lymphocyte predominance Hodgkin\u2019s disease: the use of bcl-6 and CD57 in diagnosis and differential diagnosis. Am J Surg Pathol 24(8):1068\u20131078","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"12_CR38","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1172\/JCI63186","volume":"122","author":"R Kridel","year":"2012","unstructured":"Kridel R, Sehn LH, Gascoyne RD (2012) Pathogenesis of follicular lymphoma. J Clin Invest 122(10):3424\u20133431","journal-title":"J Clin Invest"},{"issue":"1","key":"12_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrc2542","volume":"9","author":"R Kuppers","year":"2009","unstructured":"Kuppers R (2009) The biology of Hodgkin\u2019s lymphoma. Nat Rev Cancer 9(1):15\u201327","journal-title":"Nat Rev Cancer"},{"key":"12_CR40","doi-asserted-by":"publisher","unstructured":"Lenz G, Staudt LM (2010) Aggressive lymphomas. N Eng J Med 362(15):1417\u20131429. doi:10.1056\/NEJMra0807082; [pii] 362\/15\/1417","DOI":"10.1056\/NEJMra0807082"},{"issue":"11","key":"12_CR41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1182\/blood.V110.11.348.348","volume":"110","author":"G Lenz","year":"2007","unstructured":"Lenz G, Wright G, Dave S, Kohlmann A, Xiao W, Powell J et al (2007) Gene expression signatures predict overall survival in diffuse large B cell lymphoma treated with Rituximab and Chop-like chemotherapy. Blood 110(11):348 (ASH Annual Meeting Abstracts)","journal-title":"Blood"},{"issue":"22","key":"12_CR42","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","volume":"359","author":"G Lenz","year":"2008","unstructured":"Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, Vose J, Bast M, Fu K, Weisenburger DD, Greiner TC, Armitage JO, Kyle A, May L, Gascoyne RD, Connors JM, Troen G, Holte H, Kvaloy S, Dierickx D, Verhoef G, Delabie J, Smeland EB, Jares P, Martinez A, Lopez-Guillermo A, Montserrat E, Campo E, Braziel RM, Miller TP, Rimsza LM, Cook JR, Pohlman B, Sweetenham J, Tubbs RR, Fisher RI, Hartmann E, Rosenwald A, Ott G, Muller-Hermelink HK, Wrench D, Lister TA, Jaffe ES, Wilson WH, Chan WC, Staudt LM (2008) Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 359(22):2313\u20132323. doi:10.1056\/NEJMoa0802885 (Lymphoma\/Leukemia Molecular Profiling P)","journal-title":"N Engl J Med"},{"issue":"3","key":"12_CR43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ccr.2007.08.012","volume":"12","author":"IS Lossos","year":"2007","unstructured":"Lossos IS (2007) The endless complexity of lymphocyte differentiation and lymphomagenesis: IRF-4 downregulates BCL6 expression. Cancer Cell 12(3):189\u2013191","journal-title":"Cancer Cell"},{"issue":"3","key":"12_CR44","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1044-579X(03)00015-4","volume":"13","author":"IS Lossos","year":"2003","unstructured":"Lossos IS, Levy R (2003) Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions. Sem Cancer Biol 13(3):191\u2013202","journal-title":"Sem Cancer Biol"},{"issue":"6","key":"12_CR45","first-page":"1063","volume":"26","author":"RJ Lukes","year":"1966","unstructured":"Lukes RJ, Butler JJ (1966) The pathology and nomenclature of Hodgkin\u2019s disease. Cancer Res 26(6):1063\u20131083","journal-title":"Cancer Res"},{"issue":"7","key":"12_CR46","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nri844","volume":"2","author":"F Mackay","year":"2002","unstructured":"Mackay F, Browning JL (2002) BAFF: a fundamental survival factor for B cells. Nat Rev Immunol 2(7):465\u2013475","journal-title":"Nat Rev Immunol"},{"key":"12_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1146\/annurev.iy.12.040194.001001","volume":"12","author":"IC MacLennan","year":"1994","unstructured":"MacLennan IC (1994) Germinal centers. Annu Rev Immunol 12:117\u2013139","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"12_CR48","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2141.1988.tb06192.x","volume":"68","author":"R Manconi","year":"1988","unstructured":"Manconi R, Poletti A, Volpe R, Sulfaro S, Carbone A (1988) Dendritic reticulum cell pattern as a microenvironmental indicator for a distinct origin of lymphoma of follicular mantle cells. Br J Haematol 68(2):213\u2013218","journal-title":"Br J Haematol"},{"issue":"7203","key":"12_CR49","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436\u2013444","journal-title":"Nature"},{"issue":"11","key":"12_CR50","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1136\/ard.60.11.1007","volume":"60","author":"X Mariette","year":"2001","unstructured":"Mariette X (2001) Lymphomas complicating Sjogren\u2019s syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells. Ann Rheum Dis 60(11):1007\u20131010","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"12_CR51","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1182\/blood-2003-07-2594","volume":"103","author":"NA Marshall","year":"2004","unstructured":"Marshall NA, Christie LE, Munro LR, Culligan DJ, Johnston PW, Barker RN et al (2004) Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood 103(5):1755\u20131762","journal-title":"Blood"},{"issue":"3","key":"12_CR52","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1182\/blood-2002-10-3230","volume":"102","author":"A Mele","year":"2003","unstructured":"Mele A, Pulsoni A, Bianco E, Musto P, Szklo A, Sanpaolo MG et al (2003) Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood 102(3):996\u2013999","journal-title":"Blood"},{"issue":"24","key":"12_CR53","doi-asserted-by":"publisher","first-page":"7529","DOI":"10.1158\/1078-0432.CCR-11-1192","volume":"17","author":"T Miyagaki","year":"2011","unstructured":"Miyagaki T, Sugaya M, Suga H, Kamata M, Ohmatsu H, Fujita H et al (2011) IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma. Clin Cancer Res 17(24):7529\u20137538","journal-title":"Clin Cancer Res"},{"issue":"2","key":"12_CR54","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ng.518","volume":"42","author":"RD Morin","year":"2010","unstructured":"Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R et al (2010) Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 42(2):181\u2013185","journal-title":"Nat Genet"},{"issue":"7360","key":"12_CR55","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10351","volume":"476","author":"RD Morin","year":"2011","unstructured":"Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD et al (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476(7360):298\u2013303","journal-title":"Nature"},{"issue":"4","key":"12_CR56","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.ccr.2012.02.017","volume":"21","author":"ES Nakasone","year":"2012","unstructured":"Nakasone ES, Askautrud HA, Kees T, Park JH, Plaks V, Ewald AJ, Fein M, Rasch MG, Tan YX, Qiu J, Park J, Sinha P, Bissell MJ, Frengen E, Werb Z, Egeblad M (2012) Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell 21(4):488\u2013503. doi:10.1016\/j.ccr.2012.02.017","journal-title":"Cancer Cell"},{"issue":"8","key":"12_CR57","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1097\/PAS.0b013e318165b0d6","volume":"32","author":"SH Nam-Cha","year":"2008","unstructured":"Nam-Cha SH, Roncador G, Sanchez-Verde L, Montes-Moreno S, Acevedo A, Dominguez-Franjo P et al (2008) PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma. Am J Surg Pathol 32(8):1252\u20131257","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"12_CR58","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.4049\/jimmunol.1001323","volume":"185","author":"BH Nelson","year":"2010","unstructured":"Nelson BH (2010) CD20+ B cells: the other tumor-infiltrating lymphocytes. J Immunol 185(9):4977\u20134982. doi:10.4049\/jimmunol.1001323","journal-title":"J Immunol"},{"issue":"14","key":"12_CR59","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1200\/JCO.2010.33.3252","volume":"29","author":"H Nogai","year":"2011","unstructured":"Nogai H, Dorken B, Lenz G (2011) Pathogenesis of non-Hodgkin\u2019s lymphoma. J Clin Oncol 29(14):1803\u20131811. doi:10.1200\/JCO.2010.33.3252","journal-title":"J Clin Oncol"},{"issue":"7337","key":"12_CR60","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nature09730","volume":"471","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V et al (2011) Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471(7337):189\u2013195","journal-title":"Nature"},{"key":"12_CR61","doi-asserted-by":"crossref","unstructured":"Peveling-Oberhag J, Arcaini L, Hansmann ML, Zeuzem S (2013) Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management. J Hepatol 59(1):169\u2013177","DOI":"10.1016\/j.jhep.2013.03.018"},{"issue":"22","key":"12_CR62","doi-asserted-by":"publisher","first-page":"10703","DOI":"10.1158\/0008-5472.CAN-07-1708","volume":"67","author":"PP Piccaluga","year":"2007","unstructured":"Piccaluga PP, Agostinelli C, Califano A, Carbone A, Fantoni L, Ferrari S et al (2007) Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res 67(22):10703\u201310710","journal-title":"Cancer Res"},{"issue":"2","key":"12_CR63","first-page":"351","volume":"135","author":"S Poppema","year":"1989","unstructured":"Poppema S (1989) The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin\u2019s disease. Am J Pathol 135(2):351\u2013357","journal-title":"Am J Pathol"},{"key":"12_CR64","doi-asserted-by":"crossref","unstructured":"Poppema S (2005) Immunobiology and pathophysiology of Hodgkin lymphomas. Hematol Am Soc Hematol Educ Program (1):231\u2013238","DOI":"10.1182\/asheducation-2005.1.231"},{"key":"12_CR65","first-page":"323","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"S Poppema","year":"2008","unstructured":"Poppema S, Delsol G, Pileri SA, Stein H (2008) Nodular lymphocyte predominant Hodgkin lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 323\u2013325"},{"issue":"5","key":"12_CR66","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1182\/blood-2010-06-255067","volume":"117","author":"CB Reeder","year":"2011","unstructured":"Reeder CB, Ansell SM (2011) Novel therapeutic agents for B-cell lymphoma: developing rational combinations. Blood 117(5):1453\u20131462. doi:10.1182\/blood-2010-06-255067","journal-title":"Blood"},{"issue":"11","key":"12_CR67","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1182\/blood-2003-07-2365","volume":"103","author":"LM Rimsza","year":"2004","unstructured":"Rimsza LM, Roberts RA, Miller TP, Unger JM, LeBlanc M, Braziel RM, Weisenberger DD, Chan WC, Muller-Hermelink HK, Jaffe ES, Gascoyne RD, Campo E, Fuchs DA, Spier CM, Fisher RI, Delabie J, Rosenwald A, Staudt LM, Grogan TM (2004) Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project. Blood 103(11):4251\u20134258. doi:10.1182\/blood-2003-07-2365","journal-title":"Blood"},{"issue":"1","key":"12_CR68","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1182\/blood-2005-11-4742","volume":"108","author":"RA Roberts","year":"2006","unstructured":"Roberts RA, Wright G, Rosenwald AR, Jaramillo MA, Grogan TM, Miller TP, Frutiger Y, Chan WC, Gascoyne RD, Ott G, Muller-Hermelink HK, Staudt LM, Rimsza LM (2006) Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival. Blood 108(1):311\u2013318. doi:10.1182\/blood-2005-11-4742","journal-title":"Blood"},{"issue":"25","key":"12_CR69","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa012914","volume":"346","author":"A Rosenwald","year":"2002","unstructured":"Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, Lopez-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stokke T, Staudt LM (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346(25):1937\u20131947. doi:10.1056\/NEJMoa012914 (Lymphoma\/Leukemia Molecular Profiling P)","journal-title":"N Engl J Med"},{"issue":"2","key":"12_CR70","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1182\/blood-2005-12-5125","volume":"108","author":"A Sanchez-Aguilera","year":"2006","unstructured":"Sanchez-Aguilera A, Montalban C, de la Cueva P, Sanchez-Verde L, Morente MM, Garcia-Cosio M, Garcia-Larana J, Bellas C, Provencio M, Romagosa V, de Sevilla AF, Menarguez J, Sabin P, Mestre MJ, Mendez M, Fresno MF, Nicolas C, Piris MA, Garcia JF (2006) Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma. Blood 108(2):662\u2013668. doi:10.1182\/blood-2005-12-5125 (Spanish Hodgkin Lymphoma Study G)","journal-title":"Blood"},{"issue":"12","key":"12_CR71","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1182\/blood.V88.12.4638.bloodjournal88124638","volume":"88","author":"D Sansonno","year":"1996","unstructured":"Sansonno D, De Vita S, Cornacchiulo V, Carbone A, Boiocchi M, Dammacco F (1996) Detection and distribution of hepatitis C virus-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. Blood 88(12):4638\u20134645","journal-title":"Blood"},{"issue":"1","key":"12_CR72","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/eji.200324328","volume":"34","author":"D Sansonno","year":"2004","unstructured":"Sansonno D, Lauletta G, De Re V, Tucci FA, Gatti P, Racanelli V et al (2004) Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection. Eur J Immunol 34(1):126\u2013136","journal-title":"Eur J Immunol"},{"issue":"4","key":"12_CR73","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/rheumatology\/kel425","volume":"46","author":"D Sansonno","year":"2007","unstructured":"Sansonno D, Carbone A, De Re V, Dammacco F (2007) Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology 46(4):572\u2013578","journal-title":"Rheumatology"},{"key":"12_CR74","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.pathol.4.110807.092209","volume":"4","author":"R Schmitz","year":"2009","unstructured":"Schmitz R, Stanelle J, Hansmann ML et al (2009) Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma. Annu Rev Pathol 4:151\u2013174","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"12_CR75","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0165-2478(03)00050-6","volume":"88","author":"P Schneider","year":"2003","unstructured":"Schneider P, Tschopp J (2003) BAFF and the regulation of B cell survival. Immunol Lett 88(1):57\u201362","journal-title":"Immunol Lett"},{"issue":"1","key":"12_CR76","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/hon.878","volume":"27","author":"S Schreck","year":"2009","unstructured":"Schreck S, Friebel D, Buettner M, Distel L, Grabenbauer G, Young LS et al (2009) Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma. Hematol Oncol 27(1):31\u201339","journal-title":"Hematol Oncol"},{"issue":"6","key":"12_CR77","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1200\/JCO.2012.43.4589","volume":"31","author":"DW Scott","year":"2013","unstructured":"Scott DW, Chan FC, Hong F, Rogic S, Tan KL, Meissner B, Ben-Neriah S, Boyle M, Kridel R, Telenius A, Woolcock BW, Farinha P, Fisher RI, Rimsza LM, Bartlett NL, Cheson BD, Shepherd LE, Advani RH, Connors JM, Kahl BS, Gordon LI, Horning SJ, Steidl C, Gascoyne RD (2013) Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma. J Clin Oncol 31(6):692\u2013700. doi:10.1200\/JCO.2012.43.4589","journal-title":"J Clin Oncol"},{"issue":"4","key":"12_CR78","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1046\/j.1365-2567.2001.01186.x","volume":"102","author":"G Skibinski","year":"2001","unstructured":"Skibinski G, Skibinska A, James K (2001) The role of hepatocyte growth factor and its receptor c-met in interactions between lymphocytes and stromal cells in secondary human lymphoid organs. Immunol 102(4):506\u2013514","journal-title":"Immunol"},{"key":"12_CR79","doi-asserted-by":"crossref","unstructured":"Smeltzer LP, Jones JM, Ziesmer S, Grote D, Yang ZZ, Novak A, Xiu B, Ristow K, Ansell SM (2013) Changes in the tumor microenvironment associated with transformation in follicular lymphoma. J Clin Oncol 31:(suppl; abstr 8538)","DOI":"10.1200\/jco.2013.31.15_suppl.8538"},{"issue":"10","key":"12_CR80","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa0905680","volume":"362","author":"C Steidl","year":"2010","unstructured":"Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T et al (2010) Tumor-associated macrophages and survival in classic Hodgkin\u2019s lymphoma. N Engl J Med 362(10):875\u2013885","journal-title":"N Engl J Med"},{"issue":"14","key":"12_CR81","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1200\/JCO.2010.32.8401","volume":"29","author":"C Steidl","year":"2011","unstructured":"Steidl C, Connors JM, Gascoyne RD (2011) Molecular pathogenesis of Hodgkin\u2019s lymphoma: increasing evidence of the importance of the microenvironment. J Clin Oncol 29(14):1812\u20131826. doi:10.1200\/JCO.2010.32.8401","journal-title":"J Clin Oncol"},{"key":"12_CR82","first-page":"326","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"H Stein","year":"2008","unstructured":"Stein H, Delsol G, Pileri SA, Weiss LM, Poppema S, Jaffe ES (2008) Classical Hodgkin lymphoma, introduction. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, pp 326\u2013329","edition":"4"},{"issue":"3","key":"12_CR84","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/ijc.20137","volume":"110","author":"R Talamini","year":"2004","unstructured":"Talamini R, Montella M, Crovatto M, Dal Maso L, Crispo A, Negri E et al (2004) Non-Hodgkin\u2019s lymphoma and hepatitis C virus: a case-control study from northern and southern Italy. Int J Cancer 110(3):380\u2013385","journal-title":"Int J Cancer"},{"issue":"6","key":"12_CR85","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1016\/S0002-9440(10)63085-4","volume":"159","author":"S Taneda","year":"2001","unstructured":"Taneda S, Segerer S, Hudkins KL, Cui Y, Wen M, Segerer M et al (2001) Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice. Am J Pathol 159(6):2355\u20132369","journal-title":"Am J Pathol"},{"issue":"19","key":"12_CR86","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1158\/1078-0432.CCR-07-0778","volume":"13","author":"M Taskinen","year":"2007","unstructured":"Taskinen M, Karjalainen-Lindsberg ML, Nyman H, Eerola LM, Leppa S (2007) A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone. Clin Cancer Res 13(19):5784\u20135789. doi:10.1158\/1078-0432.CCR-07-0778","journal-title":"Clin Cancer Res"},{"issue":"4","key":"12_CR87","first-page":"457","volume":"54","author":"W Timens","year":"1986","unstructured":"Timens W, Visser L, Poppema S (1986) Nodular lymphocyte predominance type of Hodgkin\u2019s disease is a germinal center lymphoma. Lab Invest 54(4):457\u2013461","journal-title":"Lab Invest"},{"issue":"2","key":"12_CR88","doi-asserted-by":"publisher","first-page":"792","DOI":"10.2353\/ajpath.2010.091286","volume":"177","author":"C Tripodo","year":"2010","unstructured":"Tripodo C, Gri G, Piccaluga PP, Frossi B, Guarnotta C, Piconese S et al (2010) Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma. Am J Pathol 177(2):792\u2013802","journal-title":"Am J Pathol"},{"issue":"3","key":"12_CR89","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1182\/blood.V89.3.990","volume":"89","author":"IS Weimar","year":"1997","unstructured":"Weimar IS, de Jong D, Muller EJ, Nakamura T, van Gorp JM, de Gast GC et al (1997) Hepatocyte growth factor\/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrins. Blood 89(3):990\u20131000","journal-title":"Blood"},{"issue":"11","key":"12_CR90","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V87.11.4531.bloodjournal87114531","volume":"87","author":"WH Wilson","year":"1996","unstructured":"Wilson WH, Kingma DW, Raffeld M, Wittes RE, Jaffe ES (1996) Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b. Blood 87(11):4531\u20134537","journal-title":"Blood"},{"key":"12_CR91","doi-asserted-by":"publisher","unstructured":"Witzig TE, Vose JM, Zinzani PL, Reeder CB, Buckstein R, Polikoff JA, Bouabdallah R, Haioun C, Tilly H, Guo P, Pietronigro D, Ervin-Haynes AL, Czuczman MS (2011) An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin\u2019s lymphoma. Ann Oncol 22 (7):1622\u20131627. doi:10.1093\/annonc\/mdq626; [pii] mdq626","DOI":"10.1093\/annonc\/mdq626"},{"key":"12_CR92","unstructured":"Woolf N (1998) Relationship of neoplastic cells with their environment: tumor spread. In: Pathology basic and systemic. WB Sanders Company LTD, London, pp 249\u2013260"},{"issue":"6","key":"12_CR93","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1182\/blood-2007-05-085159","volume":"111","author":"R Yamamoto","year":"2008","unstructured":"Yamamoto R, Nishikori M, Kitawaki T, Sakai T, Hishizawa M, Tashima M et al (2008) PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma. Blood 111(6):3220\u20133224","journal-title":"Blood"},{"issue":"Suppl 3","key":"12_CR94","doi-asserted-by":"publisher","first-page":"S201","DOI":"10.1007\/s11739-012-0825-6","volume":"7","author":"AL Zignego","year":"2012","unstructured":"Zignego AL, Gragnani L, Giannini C, Laffi G (2012) The hepatitis C virus infection as a systemic disease. Int Emerg Med 7(Suppl 3):S201\u2013S208","journal-title":"Int Emerg Med"}],"container-title":["Advances in Experimental Medicine and Biology","Inflammation and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-0348-0837-8_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:37:01Z","timestamp":1676374621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-0348-0837-8_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9783034808361","9783034808378"],"references-count":93,"URL":"https:\/\/doi.org\/10.1007\/978-3-0348-0837-8_12","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"13 May 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}